ENTRY       hsa04659                    Pathway
NAME        Th17 cell differentiation - Homo sapiens (human)
DESCRIPTION Interleukin (IL)-17-producing helper T (Th17) cells serve as a subset of CD4+ T cells involved in epithelial cell- and neutrophil mediated immune responses against extracellular microbes and in the pathogenesis of autoimmune diseases. In vivo, Th17 differentiation requires antigen presentation and co-stimulation, and activation of antigen presenting-cells (APCs) to produce TGF-beta, IL-6, IL-1, IL-23 and IL-21. This initial activation results in the activation and up-regulation of STAT3, ROR(gamma)t and other transcriptional factors in CD4+ T cells, which bind to the promoter regions of the IL-17, IL-21 and IL-22 genes and induce IL-17, IL-21 and IL-22. In contrast, the differentiation of Th17 cells and their IL-17 expression are negatively regulated by IL-2, Th2 cytokine IL-4, IL-27 and Th1 cytokine IFN-gamma through STAT5, STAT6 and STAT1 activation, respectively. Retinoid acid and the combination of IL-2 and TGF-beta upregulate Foxp3, which also downregulates cytokines like IL-17 and IL-21. The inhibition of Th17 differentiation may serve as a protective strategy to 'fine-tune' the expression IL-17 so it does not cause excessive inflammation. Thus, balanced differentiation of Th cells is crucial for immunity and host protection.
CLASS       Organismal Systems; Immune system
PATHWAY_MAP hsa04659  Th17 cell differentiation
DRUG        D00094  Tretinoin (JAN/USP/INN)
            D00107  Tacrolimus (USP/INN)
            D00184  Cyclosporine (USP)
            D00316  Etretinate (JAN/USAN/INN)
            D00348  Isotretinoin (JAN/USP)
            D01112  Adapalene (JAN/USP/INN)
            D01132  Tazarotene (JAN/USAN/INN)
            D01516  Tretinoin tocoferil (JAN)
            D02754  Acitretin (USP/INN)
            D02815  Alitretinoin (USAN)
            D04636  Isotretinoin anisatil (USAN)
            D05092  Muromonab-CD3 (JAN/USAN/INN)
            D05480  Pimecrolimus (JAN/USAN/INN)
            D08556  Tacrolimus (INN)
            D09013  Teplizumab (USAN/INN)
            D09033  Voclosporin (JAN/USAN/INN)
            D09190  Anti-human thymocyte immunoglobulin, rabbit (JAN)
            D09669  Siltuximab (USAN/INN)
            D10871  Filgotinib (USAN/INN)
            D10872  Filgotinib hydrochloride (USAN)
            D10902  Afasevikumab (USAN/INN)
            D11046  Delgocitinib (JAN/USAN/INN)
            D11052  Risankizumab (USAN/INN)
            D11106  Filgotinib maleate (JAN/USAN)
            D11365  Tapinarof (JAN/USAN)
            D11537  Brepocitinib (USAN)
            D11538  Brepocitinib tosylate (USAN)
            D11817  Deucravacitinib (JAN/USAN)
            D11867  Deuruxolitinib phosphate (USAN)
            D11953  Efmarodocokin alfa (USAN/INN)
            D12121  Acapatamab (USAN)
            D12211  Ivarmacitinib (USAN)
            D12212  Ivarmacitinib sulfate (USAN)
            D12274  Cedirogant (USAN/INN)
            D12278  Izokibep (USAN/INN)
            D12368  Epcoritamab (USAN/INN)
            D12721  Avitotamig (USAN)
            D12724  Forimtamig (USAN/INN)
            D12725  Lomedeucitinib (USAN)
            D12748  Levilimab (INN)
            D12784  Casdozokitug (USAN/INN)
            D12786  Lepzacitinib (USAN)
            D12941  Zasocitinib (USAN/INN)
            D12993  Frevecitinib (USAN/INN)
            D13089  Simepdekinra (USAN)
            D13093  Icotrokinra hydrochloride (JAN/USAN)
            D13096  Tolododekin alfa (USAN)
            D13108  Icotrokinra (USAN/INN)
            D13123  Envudeucitinib (USAN/INN)
            D13124  Envudeucitinib hydrochloride (USAN)
DBLINKS     GO: 0072539
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        10148  EBI3; Epstein-Barr virus induced 3 [KO:K24476]
            112744  IL17F; interleukin 17F [KO:K05494]
            1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]
            1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]
            149233  IL23R; interleukin 23 receptor [KO:K05065]
            196  AHR; aryl hydrocarbon receptor [KO:K09093]
            2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]
            246778  IL27; interleukin 27 [KO:K22629]
            2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]
            2625  GATA3; GATA binding protein 3 [KO:K17895]
            27040  LAT; linker for activation of T cells [KO:K07362]
            30009  TBX21; T-box transcription factor 21 [KO:K10166]
            3091  HIF1A; hypoxia inducible factor 1 subunit alpha [KO:K08268]
            3108  HLA-DMA; major histocompatibility complex, class II, DM alpha [KO:K06752]
            3109  HLA-DMB; major histocompatibility complex, class II, DM beta [KO:K06752]
            3111  HLA-DOA; major histocompatibility complex, class II, DO alpha [KO:K06752]
            3112  HLA-DOB; major histocompatibility complex, class II, DO beta [KO:K06752]
            3113  HLA-DPA1; major histocompatibility complex, class II, DP alpha 1 [KO:K06752]
            3115  HLA-DPB1; major histocompatibility complex, class II, DP beta 1 [KO:K06752]
            3117  HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 [KO:K06752]
            3118  HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2 [KO:K06752]
            3119  HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 [KO:K06752]
            3120  HLA-DQB2; major histocompatibility complex, class II, DQ beta 2 [KO:K06752]
            3122  HLA-DRA; major histocompatibility complex, class II, DR alpha [KO:K06752]
            3123  HLA-DRB1; major histocompatibility complex, class II, DR beta 1 [KO:K06752]
            3125  HLA-DRB3; major histocompatibility complex, class II, DR beta 3 [KO:K06752]
            3126  HLA-DRB4; major histocompatibility complex, class II, DR beta 4 [KO:K06752]
            3127  HLA-DRB5; major histocompatibility complex, class II, DR beta 5 [KO:K06752]
            3320  HSP90AA1; heat shock protein 90 alpha family class A member 1 [KO:K04079]
            3326  HSP90AB1; heat shock protein 90 alpha family class B member 1 [KO:K04079]
            3458  IFNG; interferon gamma [KO:K04687]
            3459  IFNGR1; interferon gamma receptor 1 [KO:K05132]
            3460  IFNGR2; interferon gamma receptor 2 [KO:K05133]
            3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]
            3553  IL1B; interleukin 1 beta [KO:K04519]
            3554  IL1R1; interleukin 1 receptor type 1 [KO:K04386]
            3556  IL1RAP; interleukin 1 receptor accessory protein [KO:K04723]
            3558  IL2; interleukin 2 [KO:K05429]
            3559  IL2RA; interleukin 2 receptor subunit alpha [KO:K05068]
            3560  IL2RB; interleukin 2 receptor subunit beta [KO:K05069]
            3561  IL2RG; interleukin 2 receptor subunit gamma [KO:K05070]
            3565  IL4; interleukin 4 [KO:K05430]
            3566  IL4R; interleukin 4 receptor [KO:K05071]
            3569  IL6; interleukin 6 [KO:K05405]
            3570  IL6R; interleukin 6 receptor [KO:K05055]
            3572  IL6ST; interleukin 6 cytokine family signal transducer [KO:K05060]
            3594  IL12RB1; interleukin 12 receptor subunit beta 1 [KO:K05063]
            3605  IL17A; interleukin 17A [KO:K05489]
            3662  IRF4; interferon regulatory factor 4 [KO:K09445]
            3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]
            3717  JAK2; Janus kinase 2 [KO:K04447] [EC:2.7.10.2]
            3718  JAK3; Janus kinase 3 [KO:K11218] [EC:2.7.10.2]
            3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]
            3932  LCK; LCK proto-oncogene, Src family tyrosine kinase [KO:K05856] [EC:2.7.10.2]
            4087  SMAD2; SMAD family member 2 [KO:K04500]
            4088  SMAD3; SMAD family member 3 [KO:K23605]
            4089  SMAD4; SMAD family member 4 [KO:K04501]
            4772  NFATC1; nuclear factor of activated T cells 1 [KO:K04446]
            4773  NFATC2; nuclear factor of activated T cells 2 [KO:K17332]
            4775  NFATC3; nuclear factor of activated T cells 3 [KO:K17333]
            4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]
            4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]
            4793  NFKBIB; NFKB inhibitor beta [KO:K02581]
            4794  NFKBIE; NFKB inhibitor epsilon [KO:K05872]
            50615  IL21R; interleukin 21 receptor [KO:K05075]
            50616  IL22; interleukin 22 [KO:K05445]
            50943  FOXP3; forkhead box P3 [KO:K10163]
            51561  IL23A; interleukin 23 subunit alpha [KO:K05426]
            5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]
            5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]
            5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]
            5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]
            5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]
            5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]
            5588  PRKCQ; protein kinase C theta [KO:K18052] [EC:2.7.11.13]
            5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
            5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
            5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]
            5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]
            5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]
            5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]
            5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]
            59067  IL21; interleukin 21 [KO:K05434]
            5914  RARA; retinoic acid receptor alpha [KO:K08527]
            5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]
            6095  RORA; RAR related orphan receptor A [KO:K08532]
            6097  RORC; RAR related orphan receptor C [KO:K08534]
            6256  RXRA; retinoid X receptor alpha [KO:K08524]
            6257  RXRB; retinoid X receptor beta [KO:K08525]
            6258  RXRG; retinoid X receptor gamma [KO:K08526]
            6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]
            6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]
            6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]
            6776  STAT5A; signal transducer and activator of transcription 5A [KO:K11223]
            6777  STAT5B; signal transducer and activator of transcription 5B [KO:K11224]
            6778  STAT6; signal transducer and activator of transcription 6 [KO:K11225]
            7040  TGFB1; transforming growth factor beta 1 [KO:K13375]
            7046  TGFBR1; transforming growth factor beta receptor 1 [KO:K04674] [EC:2.7.11.30]
            7048  TGFBR2; transforming growth factor beta receptor 2 [KO:K04388] [EC:2.7.11.30]
            7297  TYK2; tyrosine kinase 2 [KO:K11219] [EC:2.7.10.2]
            7535  ZAP70; zeta chain of T cell receptor associated protein kinase 70 [KO:K07360] [EC:2.7.10.2]
            8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]
            861  RUNX1; RUNX family transcription factor 1 [KO:K08367]
            915  CD3D; CD3 delta subunit of T-cell receptor complex [KO:K06450]
            916  CD3E; CD3 epsilon subunit of T-cell receptor complex [KO:K06451]
            917  CD3G; CD3 gamma subunit of T-cell receptor complex [KO:K06452]
            919  CD247; CD247 molecule [KO:K06453]
            920  CD4; CD4 molecule [KO:K06454]
            9466  IL27RA; interleukin 27 receptor subunit alpha [KO:K19598]
COMPOUND    C00076  Calcium cation
            C00165  Diacylglycerol
            C00777  Retinoate
            C01245  D-myo-Inositol 1,4,5-trisphosphate
REFERENCE   PMID:23325835
  AUTHORS   Muranski P, Restifo NP
  TITLE     Essentials of Th17 cell commitment and plasticity.
  JOURNAL   Blood 121:2402-14 (2013)
            DOI:10.1182/blood-2012-09-378653
REFERENCE   PMID:19379825
  AUTHORS   O'Shea JJ, Steward-Tharp SM, Laurence A, Watford WT, Wei L, Adamson AS, Fan S
  TITLE     Signal transduction and Th17 cell differentiation.
  JOURNAL   Microbes Infect 11:599-611 (2009)
            DOI:10.1016/j.micinf.2009.04.007
REFERENCE   PMID:21084214
  AUTHORS   Hirahara K, Ghoreschi K, Laurence A, Yang XP, Kanno Y, O'Shea JJ
  TITLE     Signal transduction pathways and transcriptional regulation in Th17 cell differentiation.
  JOURNAL   Cytokine Growth Factor Rev 21:425-34 (2010)
            DOI:10.1016/j.cytogfr.2010.10.006
REFERENCE   PMID:18166487
  AUTHORS   Chen Z, Laurence A, O'Shea JJ
  TITLE     Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation.
  JOURNAL   Semin Immunol 19:400-8 (2007)
            DOI:10.1016/j.smim.2007.10.015
REFERENCE   PMID:22640807
  AUTHORS   Maddur MS, Miossec P, Kaveri SV, Bayry J
  TITLE     Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies.
  JOURNAL   Am J Pathol 181:8-18 (2012)
            DOI:10.1016/j.ajpath.2012.03.044
REFERENCE   PMID:23036716
  AUTHORS   Hemdan NY, Birkenmeier G, Wichmann G
  TITLE     Key molecules in the differentiation and commitment program of T helper 17 (Th17) cells up-to-date.
  JOURNAL   Immunol Lett 148:97-109 (2012)
            DOI:10.1016/j.imlet.2012.09.007
REFERENCE   PMID:18408735
  AUTHORS   Dong C
  TITLE     TH17 cells in development: an updated view of their molecular identity and genetic programming.
  JOURNAL   Nat Rev Immunol 8:337-48 (2008)
            DOI:10.1038/nri2295
REFERENCE   PMID:20054607
  AUTHORS   Torchinsky MB, Blander JM
  TITLE     T helper 17 cells: discovery, function, and physiological trigger.
  JOURNAL   Cell Mol Life Sci 67:1407-21 (2010)
            DOI:10.1007/s00018-009-0248-3
REFERENCE   PMID:19381306
  AUTHORS   Jetten AM
  TITLE     Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism.
  JOURNAL   Nucl Recept Signal 7:e003 (2009)
            DOI:10.1621/nrs.07003
REFERENCE   PMID:22133865
  AUTHORS   Oestreich KJ, Weinmann AS
  TITLE     T-bet employs diverse regulatory mechanisms to repress transcription.
  JOURNAL   Trends Immunol 33:78-83 (2012)
            DOI:10.1016/j.it.2011.10.005
REFERENCE   PMID:24325586
  AUTHORS   Manni ML, Robinson KM, Alcorn JF
  TITLE     A tale of two cytokines: IL-17 and IL-22 in asthma and infection.
  JOURNAL   Expert Rev Respir Med 8:25-42 (2014)
            DOI:10.1586/17476348.2014.854167
REFERENCE   PMID:21776333
  AUTHORS   Sha Y, Markovic-Plese S
  TITLE     A role of IL-1R1 signaling in the differentiation of Th17 cells and the development of autoimmune diseases.
  JOURNAL   Self Nonself 2:35-42 (2011)
            DOI:10.4161/self.2.1.15639
REFERENCE   PMID:20488727
  AUTHORS   Nakayama T, Yamashita M
  TITLE     The TCR-mediated signaling pathways that control the direction of helper T cell differentiation.
  JOURNAL   Semin Immunol 22:303-9 (2010)
            DOI:10.1016/j.smim.2010.04.010
REFERENCE   PMID:21151104
  AUTHORS   Lazarevic V, Chen X, Shim JH, Hwang ES, Jang E, Bolm AN, Oukka M, Kuchroo VK, Glimcher LH
  TITLE     T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding RORgammat.
  JOURNAL   Nat Immunol 12:96-104 (2011)
            DOI:10.1038/ni.1969
REFERENCE   PMID:22754770
  AUTHORS   Pan F, Barbi J, Pardoll DM
  TITLE     Hypoxia-inducible factor 1: A link between metabolism and T cell differentiation and a potential therapeutic target.
  JOURNAL   Oncoimmunology 1:510-515 (2012)
            DOI:10.4161/onci.19457
REFERENCE   PMID:18362914
  AUTHORS   Veldhoen M, Hirota K, Westendorf AM, Buer J, Dumoutier L, Renauld JC, Stockinger B
  TITLE     The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins.
  JOURNAL   Nature 453:106-9 (2008)
            DOI:10.1038/nature06881
REFERENCE   PMID:17768419
  AUTHORS   Deenick EK, Tangye SG
  TITLE     Autoimmunity: IL-21: a new player in Th17-cell differentiation.
  JOURNAL   Immunol Cell Biol 85:503-5 (2007)
            DOI:10.1038/sj.icb.7100114
REFERENCE   PMID:26253381
  AUTHORS   Meka RR, Venkatesha SH, Dudics S, Acharya B, Moudgil KD
  TITLE     IL-27-induced modulation of autoimmunity and its therapeutic potential.
  JOURNAL   Autoimmun Rev 14:1131-41 (2015)
            DOI:10.1016/j.autrev.2015.08.001
REFERENCE   PMID:16200068
  AUTHORS   Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C
  TITLE     A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17.
  JOURNAL   Nat Immunol 6:1133-41 (2005)
            DOI:10.1038/ni1261
REFERENCE   PMID:22324470
  AUTHORS   Zhu S, Qian Y
  TITLE     IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential.
  JOURNAL   Clin Sci (Lond) 122:487-511 (2012)
            DOI:10.1042/CS20110496
REL_PATHWAY hsa04010  MAPK signaling pathway
            hsa04020  Calcium signaling pathway
            hsa04064  NF-kappa B signaling pathway
            hsa04066  HIF-1 signaling pathway
            hsa04350  TGF-beta signaling pathway
            hsa04514  Cell adhesion molecules
            hsa04620  Toll-like receptor signaling pathway
            hsa04630  JAK-STAT signaling pathway
            hsa04660  T cell receptor signaling pathway
            hsa05321  Inflammatory bowel disease
            hsa05323  Rheumatoid arthritis
KO_PATHWAY  ko04659
///
